GPT and Hepatic fibrosis: A proof-of-concept study reported that OCA significantly improves insulin sensitivity and reduces liver inflammation and fibrosis markers, such as alanine aminotransferase (ALT) and enhanced liver fibrosis score, in patients with type 2 diabetes and NAFLD14.